US 8937082
Nilotinib salts and crystalline forms thereof
granted A61KA61K31/4178A61K31/506
Quick answer
US patent 8937082 (Nilotinib salts and crystalline forms thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/4178, A61K31/506, A61P, A61P35/00